1. Home
  2. ASMB vs CVEO Comparison

ASMB vs CVEO Comparison

Compare ASMB & CVEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Assembly Biosciences Inc.

ASMB

Assembly Biosciences Inc.

HOLD

Current Price

$24.34

Market Cap

442.9M

Sector

Health Care

ML Signal

HOLD

Logo Civeo Corporation (Canada)

CVEO

Civeo Corporation (Canada)

HOLD

Current Price

$34.23

Market Cap

382.5M

ML Signal

HOLD

Company Overview

Basic Information
Metric
ASMB
CVEO
Founded
2005
1977
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Hotels/Resorts
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
442.9M
382.5M
IPO Year
2010
2013

Fundamental Metrics

Financial Performance
Metric
ASMB
CVEO
Price
$24.34
$34.23
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
1
Target Price
$44.20
$37.00
AVG Volume (30 Days)
176.5K
76.7K
Earning Date
05-06-2026
05-01-2026
Dividend Yield
N/A
N/A
EPS Growth
91.78
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$7.72
Revenue Next Year
$638.39
$5.61
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$15.54
$19.75
52 Week High
$39.71
$36.50

Technical Indicators

Market Signals
Indicator
ASMB
CVEO
Relative Strength Index (RSI) 34.39 55.47
Support Level $20.23 $24.96
Resistance Level $31.21 $34.80
Average True Range (ATR) 1.75 1.54
MACD -0.42 -0.11
Stochastic Oscillator 4.26 35.75

Price Performance

Historical Comparison
ASMB
CVEO

About ASMB Assembly Biosciences Inc.

Assembly Biosciences Inc is a clinical-stage biotechnology company. The Company's pipeline includes multiple clinical-stage investigational therapies, including: (1) two long-acting helicase-primase inhibitors (HPI) for the treatment of recurrent genital herpes; (2) an orally bioavailable hepatitis delta virus entry inhibitor; and (3) a potent next-generation capsid assembly modulator designed to disrupt the replication cycle of hepatitis B virus (HBV) at several key points. The Company's pipeline also includes a novel, oral broad-spectrum non-nucleoside polymerase inhibitor (NNPI) for the treatment of transplant-related herpesviruses.

About CVEO Civeo Corporation (Canada)

Civeo Corp provides hospitality services to the natural resources industry in Canada, Australia. The company provides a full suite of services for guests, including lodging, catering and food service, housekeeping and maintenance at accommodation facilities that the company or its customers own. The company provides services that support the day-to-day operations of these facilities, such as laundry, facility management and maintenance, water and wastewater treatments, power generation, communication systems, security and logistics. The company operates in active oil, metallurgical coal, liquefied natural gas and iron ore-producing regions. The company operates in three reportable business segments Canada, and Australia. It derives maximum revenue from Australia.

Share on Social Networks: